Sepideh Amin-Hanjani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sepideh Amin-Hanjani has a total of 436 co-authors. Here are the top co-authors by number of shared publications:
Fady T. Charbel
Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA
33 shared publications- Ali Alaraj
University of Illinois at Chicago
24 shared publications - Fady T. Charbel
Department of Neurosurgery, University of Illinois at Chicago; and
20 shared publications Xinjian Du
Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL
17 shared publications- Colin P. Derdeyn
Department of Radiology, University of Virginia, Charlottesville (C.P.D.).
13 shared publications Ali Alaraj
Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL, USA
8 shared publications
Latest Publications
- 10 November 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Endovascular treatment of tentorial dural arteriovenous fistulae: multicenter CONDOR study
- 10 November 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Endovascular treatment of tentorial dural arteriovenous fistulae: multicenter CONDOR study
- 11 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2351-2363
Systemic Cardiovascular Factors and Outcomes in Dural Arteriovenous Fistulas: Insights From the CONDOR Registry
BACKGROUND: Hemorrhagic risk in dural arteriovenous fistulas (dAVFs) is largely determined by venous anatomy, but the contribution of systemic cardiovascular factors and their medical therapy remains poorly defined. This study examined associations between cardiovascular risk factors and antithrombotic use and hemorrhagic presentation, angiographic obliteration, and early functional outcomes after treatment. METHODS: We analyzed 1350 adults with intracranial dAVFs from the international Consortium for Dural Arteriovenous Fistula Outcomes Research registry, which retrospectively accrued cases across 14 centers in 4 countries between 1990 and 2017. Demographics, cardiovascular comorbidities, antithrombotic use, angioarchitectural features, treatment strategies, and follow-up outcomes were collected from prospectively maintained databases. Primary end points were hemorrhagic presentation, angiographic obliteration, and 90-day functional status after treatment. Univariable and multivariable logistic regressions were performed with model-specific adjustments. RESULTS: Hemorrhage occurred in 375 patients (27.8%) and was most strongly associated with high-grade dAVF classification and male sex; antithrombotic therapy was associated with lower odds of hemorrhagic presentation. Other cardiovascular risk factors showed no independent relationship with bleeding. Angiographic obliteration was achieved in 621 of 845 patients (73.5%). Hemorrhagic onset, high dAVF grade, and surgical treatment were independently associated with angiographic obliteration, whereas smoking and embolization demonstrated only nonsignificant trends after adjustment. At 90 days, 934 patients (88.9%) were functionally independent. Baseline modified Rankin Scale score was the strongest factor associated with 90-day functional outcome, while neither cardiovascular comorbidities nor treatment modality independently influenced functional status. CONCLUSIONS: In this large multicenter dAVF cohort, hemorrhagic presentation was most strongly associated with venous angioarchitecture. Male sex and antithrombotic therapy were also independently associated with hemorrhagic presentation. Angiographic obliteration was common, particularly among surgically treated lesions, and 90-day functional outcome was most strongly associated with baseline functional status.
- 11 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2351-2363
Systemic Cardiovascular Factors and Outcomes in Dural Arteriovenous Fistulas: Insights From the CONDOR Registry
BACKGROUND: Hemorrhagic risk in dural arteriovenous fistulas (dAVFs) is largely determined by venous anatomy, but the contribution of systemic cardiovascular factors and their medical therapy remains poorly defined. This study examined associations between cardiovascular risk factors and antithrombotic use and hemorrhagic presentation, angiographic obliteration, and early functional outcomes after treatment. METHODS: We analyzed 1350 adults with intracranial dAVFs from the international Consortium for Dural Arteriovenous Fistula Outcomes Research registry, which retrospectively accrued cases across 14 centers in 4 countries between 1990 and 2017. Demographics, cardiovascular comorbidities, antithrombotic use, angioarchitectural features, treatment strategies, and follow-up outcomes were collected from prospectively maintained databases. Primary end points were hemorrhagic presentation, angiographic obliteration, and 90-day functional status after treatment. Univariable and multivariable logistic regressions were performed with model-specific adjustments. RESULTS: Hemorrhage occurred in 375 patients (27.8%) and was most strongly associated with high-grade dAVF classification and male sex; antithrombotic therapy was associated with lower odds of hemorrhagic presentation. Other cardiovascular risk factors showed no independent relationship with bleeding. Angiographic obliteration was achieved in 621 of 845 patients (73.5%). Hemorrhagic onset, high dAVF grade, and surgical treatment were independently associated with angiographic obliteration, whereas smoking and embolization demonstrated only nonsignificant trends after adjustment. At 90 days, 934 patients (88.9%) were functionally independent. Baseline modified Rankin Scale score was the strongest factor associated with 90-day functional outcome, while neither cardiovascular comorbidities nor treatment modality independently influenced functional status. CONCLUSIONS: In this large multicenter dAVF cohort, hemorrhagic presentation was most strongly associated with venous angioarchitecture. Male sex and antithrombotic therapy were also independently associated with hemorrhagic presentation. Angiographic obliteration was common, particularly among surgically treated lesions, and 90-day functional outcome was most strongly associated with baseline functional status.
- Open Access
- 24 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadx4374
Vasa vasorum plexus formation in intracranial aneurysm associates with microcalcification and wall thickening
Intracranial aneurysms (IAs) affect about 3% of the population, often leading to catastrophic outcomes upon rupture. Vasa vasorum, microvessels supplying arterial walls, are conjectured to induce inflammation and leakage in IAs that drive adverse remodeling. Using scanning immunofluorescent multiphoton imaging and micro–computed tomography to visualize intact IA specimens, we identified an extensive vasa vasorum plexus in the IA wall. Our quantitative analyses show significant colocalization of vasa vasorum with calcifications, a strong correlation with increased wall thickness ( R 2 = 0.96, P < 0.001), and associations with well-defined multiaxially oriented collagen fibers. These findings highlight a more nuanced role for vasa vasorum, suggesting both adverse and protective remodeling influences, which may critically affect IA rupture risk. Contrary to the prevailing view of vasa vasorum as solely adverse, this study underscores the contribution to IA wall stability and the need to elucidate their functional impact on IA pathophysiology. Hence, these microvessels warrant further investigation for therapeutic targeting.
- 24 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadx4374
Open AccessVasa vasorum plexus formation in intracranial aneurysm associates with microcalcification and wall thickening
Intracranial aneurysms (IAs) affect about 3% of the population, often leading to catastrophic outcomes upon rupture. Vasa vasorum, microvessels supplying arterial walls, are conjectured to induce inflammation and leakage in IAs that drive adverse remodeling. Using scanning immunofluorescent multiphoton imaging and micro–computed tomography to visualize intact IA specimens, we identified an extensive vasa vasorum plexus in the IA wall. Our quantitative analyses show significant colocalization of vasa vasorum with calcifications, a strong correlation with increased wall thickness ( R 2 = 0.96, P < 0.001), and associations with well-defined multiaxially oriented collagen fibers. These findings highlight a more nuanced role for vasa vasorum, suggesting both adverse and protective remodeling influences, which may critically affect IA rupture risk. Contrary to the prevailing view of vasa vasorum as solely adverse, this study underscores the contribution to IA wall stability and the need to elucidate their functional impact on IA pathophysiology. Hence, these microvessels warrant further investigation for therapeutic targeting.
- Open Access
- 1 October 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus: Video
- Vol. 13 (2) , V5
Preoperative embolization and craniotomy for the treatment of a tentorial dural arteriovenous fistula
This is a video presentation of a complex tentorial arteriovenous fistula that required multimodal treatment with preoperative embolization followed by craniotomy for clip ligation with several teaching points. A Cognard type IV fistula has multiple arterial feeders and direct cortical venous drainage with venous ectasia. A multimodal approach was required, consisting of endovascular embolization of occipital feeders followed by tailored craniotomy for clip ligation of the venous outflow of the fistula. The video discusses important nuances for the successful treatment of complex arteriovenous fistulas while minimizing morbidity. The video can be found here: https://stream.cadmore.media/r10.3171/2025.7.FOCVID2597
- 1 October 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus: Video
- Vol. 13 (2) , V5
Open AccessPreoperative embolization and craniotomy for the treatment of a tentorial dural arteriovenous fistula
This is a video presentation of a complex tentorial arteriovenous fistula that required multimodal treatment with preoperative embolization followed by craniotomy for clip ligation with several teaching points. A Cognard type IV fistula has multiple arterial feeders and direct cortical venous drainage with venous ectasia. A multimodal approach was required, consisting of endovascular embolization of occipital feeders followed by tailored craniotomy for clip ligation of the venous outflow of the fistula. The video discusses important nuances for the successful treatment of complex arteriovenous fistulas while minimizing morbidity. The video can be found here: https://stream.cadmore.media/r10.3171/2025.7.FOCVID2597
- Open Access
- 21 July 2025
- Published by Elsevier in World Neurosurgery
- Vol. 201, 124308
Indications and Outcomes of Intracranial Bypass: A Systematic Review and Meta-Analysis
- 21 July 2025
- Published by Elsevier in World Neurosurgery
- Vol. 201, 124308
Open AccessIndications and Outcomes of Intracranial Bypass: A Systematic Review and Meta-Analysis
- 3 June 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (4) , 606-609
Simple Microvascular Decompression for Hemifacial Spasm Caused by Dolichoectatic Vertebral Artery
BACKGROUND AND IMPORTANCE: Hemifacial spasm (HFS) secondary to a dolichoectatic vertebral artery (VA) is a rare but debilitating condition. Macrovascular displacement of the vessel away from the nerve using a Teflon sling is an effective, but not always feasible, method. Transection, relocation, and reanastomosis of the dolichoectatic VA has also been described but presents a significant surgical challenge and carries a higher risk profile. In this case report, we demonstrate that simple microvascular decompression by translocation of the compression point away from the root entry zone (REZ) is an effective measure in treating HFS in this setting. CLINICAL PRESENTATION: A 67-year-old patient presented with debilitating left-sided HFS secondary to a large torturous VA abutting the facial nerve root entry point at the brainstem. The patient underwent retrosigmoid craniotomy, and the dolichoectatic VA was able to be mobilized away from the REZ, although compression remained along the cisternal segment. Using Teflon pledgets, the compression point caused by the VA at the REZ was carefully padded, and despite residual compression in the more distal cisternal nerve segment, the patient experienced complete resolution of symptoms. CONCLUSION: HFS caused by a dolichoectatic vessel poses a challenge for complete surgical decompression. We demonstrate that decompression of the REZ alone represents a simple and effective solution, resulting in complete resolution of the symptoms without the need to resort to more complex and potentially riskier options.
- 3 June 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (4) , 606-609
Simple Microvascular Decompression for Hemifacial Spasm Caused by Dolichoectatic Vertebral Artery
BACKGROUND AND IMPORTANCE: Hemifacial spasm (HFS) secondary to a dolichoectatic vertebral artery (VA) is a rare but debilitating condition. Macrovascular displacement of the vessel away from the nerve using a Teflon sling is an effective, but not always feasible, method. Transection, relocation, and reanastomosis of the dolichoectatic VA has also been described but presents a significant surgical challenge and carries a higher risk profile. In this case report, we demonstrate that simple microvascular decompression by translocation of the compression point away from the root entry zone (REZ) is an effective measure in treating HFS in this setting. CLINICAL PRESENTATION: A 67-year-old patient presented with debilitating left-sided HFS secondary to a large torturous VA abutting the facial nerve root entry point at the brainstem. The patient underwent retrosigmoid craniotomy, and the dolichoectatic VA was able to be mobilized away from the REZ, although compression remained along the cisternal segment. Using Teflon pledgets, the compression point caused by the VA at the REZ was carefully padded, and despite residual compression in the more distal cisternal nerve segment, the patient experienced complete resolution of symptoms. CONCLUSION: HFS caused by a dolichoectatic vessel poses a challenge for complete surgical decompression. We demonstrate that decompression of the REZ alone represents a simple and effective solution, resulting in complete resolution of the symptoms without the need to resort to more complex and potentially riskier options.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , 1636-1641
ARISE II Consensus on the Management of Intracranial Atherosclerotic Disease
Intracranial atherosclerotic disease (ICAD) is one of the leading causes of ischemic stroke worldwide. Despite advances in its diagnosis and management, there is no clear consensus on best practices to manage ICAD. This report summarizes the ARISE II (Roundtable Discussion With Industry and Stroke Experts) consensus in treating ICAD. The consensus underscored the importance of lifestyle modification and medical management in patients with ICAD. Patients who fail medical management are candidates for endovascular treatment. Open surgery is not recommended in patients who lack demonstrated hemodynamic insufficiency. The consensus also identified gaps in knowledge about the optimal duration of antithrombotics, the effect of the CYP2C19 genotype on medical management, the need for newer devices, and the standardization of antithrombotic protocols before stenting in an acute setting. Optical coherence tomography requires additional clinical data before defining its role in the diagnosis of ICAD.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , 1636-1641
ARISE II Consensus on the Management of Intracranial Atherosclerotic Disease
Intracranial atherosclerotic disease (ICAD) is one of the leading causes of ischemic stroke worldwide. Despite advances in its diagnosis and management, there is no clear consensus on best practices to manage ICAD. This report summarizes the ARISE II (Roundtable Discussion With Industry and Stroke Experts) consensus in treating ICAD. The consensus underscored the importance of lifestyle modification and medical management in patients with ICAD. Patients who fail medical management are candidates for endovascular treatment. Open surgery is not recommended in patients who lack demonstrated hemodynamic insufficiency. The consensus also identified gaps in knowledge about the optimal duration of antithrombotics, the effect of the CYP2C19 genotype on medical management, the need for newer devices, and the standardization of antithrombotic protocols before stenting in an acute setting. Optical coherence tomography requires additional clinical data before defining its role in the diagnosis of ICAD.
- Open Access
- 15 April 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (6) , 108322
Stroke risk prediction in symptomatic anterior circulation ICAD: Analysis of regional QMRA flow from the MYRIAD study
- 15 April 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (6) , 108322
Open AccessStroke risk prediction in symptomatic anterior circulation ICAD: Analysis of regional QMRA flow from the MYRIAD study
- 1 April 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (4) , 828-837
Evaluation of Sex-Related Differences in Cerebrovascular Bypass Patency: Review of 357 Direct Cerebral Bypasses
BACKGROUND: Demographics and comorbid conditions play a role in vascular health, yet their specific impact on cerebrovascular bypass patency remains unclear. METHODS: An institutional database of 357 patients with intracranial bypass procedures between August 2001 and May 2022 was retrospectively reviewed. Patients with bypass for all causes (eg, aneurysm, atherosclerotic disease, moyamoya disease) were included. Medical history, surgical technique, and flow-related measurements (intraoperatively and on quantitative magnetic resonance angiography at follow-up) were compared across biological sex and in relation to bypass patency. Bonferroni correction was applied to the initial analysis ( P ≤0.00167). The remaining analyses were considered exploratory. Propensity score–matched analysis matched cardiovascular risk factors and compared women and men in bypass patency. RESULTS: Of 357 patients, 141 were men (39.5%) and 216 were women (60.5%) with average age of 49.0±16.7 years and an average follow-up of 1.97 years. Bypass patency at last follow-up was 84.4% (n=114) for men versus 69.2% (n=148) for women ( P =0.001). Differences were seen in underlying diagnoses, with more aneurysm and moyamoya cases represented in female sex ( P P =0.032), moyamoya disease ( P =0.035), and for atherosclerotic disease ( P =0.159). Medical comorbidities were seen at higher rates in men, with comorbidity score of 2.7 versus 2.1 ( P P =0.028), with no differences in intraoperative bypass flow, cut flow index, or follow-up quantitative magnetic resonance angiography. After removing cases using interposition grafts, similar differences were redemonstrated. Propensity score–matched analysis found women have a 2.71 higher chance of bypass occlusion after adjusting for cut flow index ( P =0.017 [95% CI, 1.19–6.18]). CONCLUSIONS: Biological sex appears to play a role in bypass patency, across diagnoses. Women were less likely to have patent bypasses at the last follow-up, despite having fewer medical comorbidities than men and despite having similar intraoperative and perioperative flows.
- 1 April 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (4) , 828-837
Evaluation of Sex-Related Differences in Cerebrovascular Bypass Patency: Review of 357 Direct Cerebral Bypasses
BACKGROUND: Demographics and comorbid conditions play a role in vascular health, yet their specific impact on cerebrovascular bypass patency remains unclear. METHODS: An institutional database of 357 patients with intracranial bypass procedures between August 2001 and May 2022 was retrospectively reviewed. Patients with bypass for all causes (eg, aneurysm, atherosclerotic disease, moyamoya disease) were included. Medical history, surgical technique, and flow-related measurements (intraoperatively and on quantitative magnetic resonance angiography at follow-up) were compared across biological sex and in relation to bypass patency. Bonferroni correction was applied to the initial analysis ( P ≤0.00167). The remaining analyses were considered exploratory. Propensity score–matched analysis matched cardiovascular risk factors and compared women and men in bypass patency. RESULTS: Of 357 patients, 141 were men (39.5%) and 216 were women (60.5%) with average age of 49.0±16.7 years and an average follow-up of 1.97 years. Bypass patency at last follow-up was 84.4% (n=114) for men versus 69.2% (n=148) for women ( P =0.001). Differences were seen in underlying diagnoses, with more aneurysm and moyamoya cases represented in female sex ( P P =0.032), moyamoya disease ( P =0.035), and for atherosclerotic disease ( P =0.159). Medical comorbidities were seen at higher rates in men, with comorbidity score of 2.7 versus 2.1 ( P P =0.028), with no differences in intraoperative bypass flow, cut flow index, or follow-up quantitative magnetic resonance angiography. After removing cases using interposition grafts, similar differences were redemonstrated. Propensity score–matched analysis found women have a 2.71 higher chance of bypass occlusion after adjusting for cut flow index ( P =0.017 [95% CI, 1.19–6.18]). CONCLUSIONS: Biological sex appears to play a role in bypass patency, across diagnoses. Women were less likely to have patent bypasses at the last follow-up, despite having fewer medical comorbidities than men and despite having similar intraoperative and perioperative flows.
- Open Access
Evaluation of Sex-Related Differences in Cerebrovascular Bypass Patency: An Institutional Review of 357 Direct Cerebral Bypasses
Introduction: Demographics and comorbid conditions play a role in vascular health, yet their specific impact on cerebrovascular bypass patency remains unclear. Methods: An institutional database of 357 patients with intracranial bypass procedures between 08/2001-05/2022 was retrospectively reviewed. Patients with bypass for all causes (e.g., aneurysm, atherosclerotic disease, Moyamoya disease) were included. Medical history, surgical technique, and flow-related measurements (intraoperatively and on quantitative MRA at follow-up) were compared across biological sex and in relation to bypass patency. Results: Of 357 patients, 141 were male (39.5%) and 216 were female (60.5%) with average age 49.0+/-16.7. Bypass patency at last follow-up was 84.4% for men vs. 69.2% for women (p=0.001). Significant differences were seen in underlying diagnoses, with more aneurysm and Moyamoya cases represented in female sex (p<0.001); irrespective of diagnosis, lower patency rates were seen in women when considering bypass for aneurysm (p=0.032), Moyamoya disease (p=0.035), and for atherosclerotic disease (p=0.159). Medical comorbidities were seen at higher rates in men, with comorbidity score 2.7 vs. 2.1 (p<0.001). Cut flow was higher in men 59.2 vs. 51.1 (p=0.028), but no significant differences were seen in intraoperative bypass flow, cut flow index (CFI), or follow-up QMRA. After removing cases using interposition grafts, similar differences were redemonstrated. Propensity score matched analysis found females have a 2.71 higher chance of bypass occlusion after adjusting for CFI (p=0.017, 95% CI: 1.19-6.18). Conclusion: Biological sex appears to play a significant role in bypass patency, across diagnoses. Women were significantly less likely to have patent bypasses at last follow-up, despite having less medical comorbidities than men and despite having similar intraoperative and perioperative flows. Further study is required to better elucidate the influence of sex on long-term bypass patency.
Open AccessEvaluation of Sex-Related Differences in Cerebrovascular Bypass Patency: An Institutional Review of 357 Direct Cerebral Bypasses
Introduction: Demographics and comorbid conditions play a role in vascular health, yet their specific impact on cerebrovascular bypass patency remains unclear. Methods: An institutional database of 357 patients with intracranial bypass procedures between 08/2001-05/2022 was retrospectively reviewed. Patients with bypass for all causes (e.g., aneurysm, atherosclerotic disease, Moyamoya disease) were included. Medical history, surgical technique, and flow-related measurements (intraoperatively and on quantitative MRA at follow-up) were compared across biological sex and in relation to bypass patency. Results: Of 357 patients, 141 were male (39.5%) and 216 were female (60.5%) with average age 49.0+/-16.7. Bypass patency at last follow-up was 84.4% for men vs. 69.2% for women (p=0.001). Significant differences were seen in underlying diagnoses, with more aneurysm and Moyamoya cases represented in female sex (p<0.001); irrespective of diagnosis, lower patency rates were seen in women when considering bypass for aneurysm (p=0.032), Moyamoya disease (p=0.035), and for atherosclerotic disease (p=0.159). Medical comorbidities were seen at higher rates in men, with comorbidity score 2.7 vs. 2.1 (p<0.001). Cut flow was higher in men 59.2 vs. 51.1 (p=0.028), but no significant differences were seen in intraoperative bypass flow, cut flow index (CFI), or follow-up QMRA. After removing cases using interposition grafts, similar differences were redemonstrated. Propensity score matched analysis found females have a 2.71 higher chance of bypass occlusion after adjusting for CFI (p=0.017, 95% CI: 1.19-6.18). Conclusion: Biological sex appears to play a significant role in bypass patency, across diagnoses. Women were significantly less likely to have patent bypasses at last follow-up, despite having less medical comorbidities than men and despite having similar intraoperative and perioperative flows. Further study is required to better elucidate the influence of sex on long-term bypass patency.